Literature DB >> 2839714

Sequence of the fourth gene of human rotaviruses recovered from asymptomatic or symptomatic infections.

M Gorziglia1, K Green, K Nishikawa, K Taniguchi, R Jones, A Z Kapikian, R M Chanock.   

Abstract

The complete nucleotide sequence of the fourth gene of symptomatic (Wa, DS-1, P, and VA70) and asymptomatic (M37, 1076, McN13, and ST3) rotaviruses of serotype 1, 2, 3, or 4 was determined by the dideoxy chain termination method. In each strain, the fourth gene, which encodes the outer capsid protein VP3, is 2,359 base pairs in length and has 5'- and 3'-noncoding regions of 9 and 25 nucleotides, respectively. The gene has a single long open reading frame of 2,325 base pairs that is capable of coding for a protein of 775 amino acids. A total of 14 N-terminal and 12 C-terminal amino acids are completely conserved or almost completely conserved, respectively, among nine human rotavirus VP3 genes that have been sequenced. In addition, there is conservation of arginine at the two trypsin cleavage sites as well as conservation of clusters of amino acids in different regions of the two VP3 cleavage products, VP8 and VP5. Three distinct forms of VP3 were identified among the nine human rotavirus strains analyzed. Three symptomatic rotaviruses (serotypes 1, 3, and 4) possess highly related VP3 genes (92.2 to 97% nucleotide identity). Two symptomatic serotype 2 rotaviruses possess VP3 genes which are even more closely related to each other (98.6% nucleotide identity) and only moderately related to the aforementioned VP3 genes of serotypes 1, 3, and 4 (87.4 to 88.2% nucleotide identity). The four asymptomatic rotaviruses, which constitute the third group, possess highly related VP3 genes (95.5 to 97.5% nucleotide identity) which are distinct from those of the virulent rotaviruses (73 to 74.8% nucleotide identity). At 91 positions in the protein sequence of VP3, an amino acid is conserved among the asymptomatic rotaviruses, while a different amino acid is conserved among the symptomatic rotaviruses. Notably, five regions are conserved among the symptomatic rotaviruses, while a different set of sequences are conserved among the asymptomatic rotaviruses. It is possible that some or all of these regions of sequence dimorphism may be responsible for the difference in virulence of these two groups of human rotaviruses. There are 13 regions in the VP3 protein sequence which exhibit the greatest variability; the majority of these variable regions are observed between amino acids 106 to 192. These regions may represent potential antigenic sites related to heterotypic rotavirus neutralization.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2839714      PMCID: PMC253736          DOI: 10.1128/JVI.62.8.2978-2984.1988

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

1.  The rhesus rotavirus gene encoding protein VP3: location of amino acids involved in homologous and heterologous rotavirus neutralization and identification of a putative fusion region.

Authors:  E R Mackow; R D Shaw; S M Matsui; P T Vo; M N Dang; H B Greenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

2.  Proteolytic enhancement of rotavirus infectivity: molecular mechanisms.

Authors:  M K Estes; D Y Graham; B B Mason
Journal:  J Virol       Date:  1981-09       Impact factor: 5.103

3.  Structural polypeptides of simian rotavirus SA11 and the effect of trypsin.

Authors:  R T Espejo; S López; C Arias
Journal:  J Virol       Date:  1981-01       Impact factor: 5.103

4.  Identification of the rotaviral gene that codes for hemagglutination and protease-enhanced plaque formation.

Authors:  A R Kalica; J Flores; H B Greenberg
Journal:  Virology       Date:  1983-02       Impact factor: 3.616

5.  Use of transcription probes for genotyping rotavirus reassortants.

Authors:  J Flores; H B Greenberg; J Myslinski; A R Kalica; R G Wyatt; A Z Kapikian; R M Chanock
Journal:  Virology       Date:  1982-09       Impact factor: 3.616

6.  Biochemical mapping of the simian rotavirus SA11 genome.

Authors:  B B Mason; D Y Graham; M K Estes
Journal:  J Virol       Date:  1983-05       Impact factor: 5.103

7.  Gene coding assignments for growth restriction, neutralization and subgroup specificities of the W and DS-1 strains of human rotavirus.

Authors:  H B Greenberg; J Flores; A R Kalica; R G Wyatt; R Jones
Journal:  J Gen Virol       Date:  1983-02       Impact factor: 3.891

8.  Human reovirus-like agent as the major pathogen associated with "winter" gastroenteritis in hospitalized infants and young children.

Authors:  A Z Kapikian; H W Kim; R G Wyatt; W L Cline; J O Arrobio; C D Brandt; W J Rodriguez; D A Sack; R M Chanock; R H Parrott
Journal:  N Engl J Med       Date:  1976-04-29       Impact factor: 91.245

9.  Human rotavirus type 2: cultivation in vitro.

Authors:  R G Wyatt; W D James; E H Bohl; K W Theil; L J Saif; A R Kalica; H B Greenberg; A Z Kapikian; R M Chanock
Journal:  Science       Date:  1980-01-11       Impact factor: 47.728

10.  Importance of a new virus in acute sporadic enteritis in children.

Authors:  G P Davidson; R F Bishop; R R Townley; I H Holmes
Journal:  Lancet       Date:  1975-02-01       Impact factor: 79.321

View more
  59 in total

1.  Detection and characterization of rotaviruses in hospitalized neonates in Blantyre, Malawi.

Authors:  N A Cunliffe; S Rogerson; W Dove; B D M Thindwa; J Greensill; C D Kirkwood; R L Broadhead; C A Hart
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

2.  Human rotavirus strain with unique VP4 neutralization epitopes as a result of natural reassortment between members of the AU-1 and Wa genogroups.

Authors:  O Nakagomi; E Kaga; T Nakagomi
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

3.  Rotavirus YM gene 4: analysis of its deduced amino acid sequence and prediction of the secondary structure of the VP4 protein.

Authors:  S López; I López; P Romero; E Méndez; X Soberón; C F Arias
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

4.  Serotype-specific epitope(s) present on the VP8 subunit of rotavirus VP4 protein.

Authors:  G Larralde; B G Li; A Z Kapikian; M Gorziglia
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

5.  High-resolution molecular and antigen structure of the VP8* core of a sialic acid-independent human rotavirus strain.

Authors:  Nilah Monnier; Kyoko Higo-Moriguchi; Zhen-Yu J Sun; B V Venkataram Prasad; Koki Taniguchi; Philip R Dormitzer
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

6.  Sequence conservation within neutralization epitope regions of VP7 and VP4 proteins of human serotype G4 rotavirus isolates.

Authors:  E A Palombo; R F Bishop; R G Cotton
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

7.  Genetic characterization of a novel, naturally occurring recombinant human G6P[6] rotavirus.

Authors:  Mustafizur Rahman; Karolien De Leener; Truus Goegebuer; Elke Wollants; Ingrid Van der Donck; Lieve Van Hoovels; Marc Van Ranst
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

8.  Serologic analysis of human rotavirus serotypes P1A and P2 by using monoclonal antibodies.

Authors:  L Padilla-Noriega; R Werner-Eckert; E R Mackow; M Gorziglia; G Larralde; K Taniguchi; H B Greenberg
Journal:  J Clin Microbiol       Date:  1993-03       Impact factor: 5.948

9.  Isolation of a human rotavirus containing a bovine rotavirus VP4 gene that suppresses replication of other rotaviruses in coinfected cells.

Authors:  R L Ward; Q Jin; O Nakagomi; D S Sander; J R Gentsch
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

10.  Human rotavirus VP4 contains strain-specific, serotype-specific and cross-reactive neutralization sites.

Authors:  C D Kirkwood; R F Bishop; B S Coulson
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.